Herboxidiene: 1H-NMR
OH OH G T A G A G C C A C A G C C A A C A C A T T T G G T T A T A T
4nM E7107 resistant clone#1 SF3B1 residue 1078 WT = GTC = Valine Mut = GCC = Alanine
G T G A C T C C T G T G T G C G T C C C T G C A C T C T G G T G
4nM E7107 resistant clone#3 PHF5A residue 36 WT = TAT= Tyrosine Mut = TGT = Cysteine
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4nM E7107 resistant clone#4 SF3B1 residue 1074 WT = CGT = Arginine Mut = CAT = Histidine
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4nM E7107 resistant clone#6 SF3B1 residue 1078 WT = GTC = Valine Mut = ATC = Isoleucine
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4nM E7107 resistant clone#7 SF3B1 residue 1078 WT = GTC = Valine Mut = GCC = Alanine Black box indicates affected codons, the respective coding and amino acid change were shown above sequencing results.
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20nM Herboxidiene resistant clone#3 PHF5A residue 36 WT = TAT= Tyrosine Mut = TGT = Cysteine PHF5A Y36C presents better resistance to herboxidiene analogues than pladienolide and FR901464 analogues whereas SF3B1 R1074H mutation presents with the opposite preference. X-axis is the GI50 ratios between the PHF5A Y36C mutation carrying clone versus the parental line of the same compound in logarithm scale. Y-axis is the GI50 ratios between the SF3B1 R1074H mutation carrying clone versus the parental line in logarithum scale. Green line is at 45 o diagonal representing equal GI50 shift of the same compound in both resistant clones as compared to the parental line. (a) Y36C PHF5A accounts for ~92% of total PHF5A mRNA expression in the engineered PHF5A Y36C over-expressing lines. Screenshot from IGV browser is shown. Note the sequence below is of reverse complimentary and the T to C conversion is corresponding to tyrosine to cycsteine change. (b) QC summary of differential splicing analysis between PHF5A Y36C cells treated with DMSO versus that of PHF5A WT cells showed minimal difference between two genotypes as measured by number of events and average fold change. Box shows the inter-quartile range (IQR) of the dataset whereas the whiskers illustrate 1.5xIQR. QC summary of parallel splicing modulator treated samples can be found in Fig. 4 for comparison. 
Supplementary Figure 9:
Gene level analysis of splicing modulator regulated genes.
(a) Venn Diagram showing the overlap of genes regulated by 100nM E7107 as compared to DMSO in PHF5A WT cells (purple) and genes regulated by 100nM E7107 in Y36C (pink) cells. (b) Gene Set Enrichment Analysis (GSEA) using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database of PHF5A WT specific genes identified from (a). (c) GSEA using KEGG pathway database of PHF5A Y36C specific genes identified from (a). Only the top ten enriched pathways were shown in (b) and (c). Raw data used for generation of (a)(b)(c) were included as supplementary Table 6 . Hypothetical model for MCL1 like "exon -weaker intron -exon-stronger intron -exon" strucutre which underwent IR/ES switch determined by the genotype of PHF5A upon E7107 treatment. In the absence of E7107 treatment, in PHF5A WT and Y36C cells, both introns are recognized by splicesome leading to production of mature mRNAs. In PHF5A WT cells, both introns are sensitive to E7107 leading to IR of both introns. However, in PHF5A Y36C cells as the association of the compound with the PHF5A-SF3B1 interface is reduced, E7107 would become less efficient in the competition with the downstream, stronger intron while maintaining its inhibition with the upstream, weaker intron. Therefore, splicesome would be able to recognize the 3' splice site of the downstream stronger intron and lead to direct ligation of exon 1 to exon 3. 
Supplementary Figure 16:
Purity and Identity of compounds used in the study. LCMS profile (top) and 1H-NMR spectra (bottom) of E7107 are shown. The first peak in the LCMS at 0.2 min corresponds to the solvent front and is omitted from the integration. The main peak in the mass spec shows the expected mass for the compound. The NMR spectra is annotated with the chemical shifts (blue font) and the number of protons integrated (red font). The large peaks with no integration correspond to solvent peaks.
